[{"address1": "3805 Old Easton Road", "city": "Doylestown", "state": "PA", "zip": "18902", "country": "United States", "phone": "(215) 948-4119", "website": "https://aprea.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidates are APR-1051, an orally bioavailable small-molecule inhibitor of WEE1 kinase that is in Phase 1 clinical trial for the treatment of patients with advanced solid tumors with biomarkers; and ATRN-119, an ATR inhibitor, which is in Phase 1/2a clinical trial for solid tumor indications. The company is headquartered in Doylestown, Pennsylvania.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Dr. Oren  Gilad Ph.D.", "age": 56, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 575490, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John P. Hamill CPA", "age": 60, "title": "Senior VP, CFO, Principal Accounting Officer & Secretary", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 444280, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lars B. Abrahmsen Ph.D.", "age": 67, "title": "Senior VP & Chief Scientific Officer", "yearBorn": 1957, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian  Wiley", "age": 56, "title": "Senior Vice President of Corporate Development & Strategy", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michel  Afargan Ph.D.", "title": "Head of Pharmacology Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ze'ev  Weiss B.Sc., C.P.A.", "age": 62, "title": "Chief Business Advisor", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Andrea  Epstein", "title": "Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.69, "open": 1.7113, "dayLow": 1.66, "dayHigh": 1.72, "regularMarketPreviousClose": 1.69, "regularMarketOpen": 1.7113, "regularMarketDayLow": 1.66, "regularMarketDayHigh": 1.72, "payoutRatio": 0.0, "beta": 1.609, "forwardPE": -1.6386274, "volume": 23235, "regularMarketVolume": 23235, "averageVolume": 36726, "averageVolume10days": 78870, "averageDailyVolume10Day": 78870, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 9245132, "fiftyTwoWeekLow": 1.412, "fiftyTwoWeekHigh": 5.01, "priceToSalesTrailing12Months": 7.197596, "fiftyDayAverage": 1.71552, "twoHundredDayAverage": 2.748155, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -8616638, "profitMargins": 0.0, "floatShares": 3482331, "sharesOutstanding": 5531370, "sharesShort": 72909, "sharesShortPriorMonth": 59011, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.013200001, "heldPercentInsiders": 0.119049996, "heldPercentInstitutions": 0.40937, "shortRatio": 2.19, "shortPercentOfFloat": 0.0149, "impliedSharesOutstanding": 5531370, "bookValue": 2.821, "priceToBook": 0.5924849, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -14081279, "trailingEps": -2.34, "forwardEps": -1.02, "lastSplitFactor": "1:20", "lastSplitDate": 1676246400, "enterpriseToRevenue": -6.708, "enterpriseToEbitda": 0.566, "52WeekChange": -0.55526316, "SandP52WeekChange": 0.12632763, "quoteType": "EQUITY", "currentPrice": 1.6714, "targetHighPrice": 20.0, "targetLowPrice": 10.0, "targetMeanPrice": 13.66667, "targetMedianPrice": 11.0, "recommendationMean": 1.66667, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 19275720, "totalCashPerShare": 3.485, "ebitda": -15233977, "totalDebt": 0, "quickRatio": 5.735, "currentRatio": 5.901, "totalRevenue": 1284475, "revenuePerShare": 0.216, "returnOnAssets": -0.35696, "returnOnEquity": -0.59798, "grossProfits": -8961755, "freeCashflow": -8462202, "operatingCashflow": -13251990, "revenueGrowth": -0.573, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -25.147772, "financialCurrency": "USD", "symbol": "APRE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "REGULAR", "corporateActions": [], "regularMarketTime": 1751388456, "exchange": "NCM", "messageBoardId": "finmb_329831339", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.100598, "regularMarketPrice": 1.6714, "shortName": "Aprea Therapeutics, Inc.", "longName": "Aprea Therapeutics, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1570109400000, "regularMarketChange": -0.018600106, "regularMarketDayRange": "1.66 - 1.72", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 36726, "fiftyTwoWeekLowChange": 0.2594, "fiftyTwoWeekLowChangePercent": 0.18371107, "fiftyTwoWeekRange": "1.412 - 5.01", "fiftyTwoWeekHighChange": -3.3386002, "fiftyTwoWeekHighChangePercent": -0.6663872, "fiftyTwoWeekChangePercent": -55.526318, "earningsTimestamp": 1747224002, "earningsTimestampStart": 1754915400, "earningsTimestampEnd": 1755261000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.34, "epsForward": -1.02, "epsCurrentYear": -0.83, "priceEpsCurrentYear": -2.0137348, "fiftyDayAverageChange": -0.044120073, "fiftyDayAverageChangePercent": -0.025718192, "twoHundredDayAverageChange": -1.0767552, "twoHundredDayAverageChangePercent": -0.39181018, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.7 - Buy", "cryptoTradeable": false, "displayName": "Aprea Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-07-01"}]